Hepatitis Monthly

Published by: Kowsar

The Role of Interleukin-6 and Interleukin-8 Gene Polymorphisms in Non-Alcoholic Steatohepatitis

Mustafa Cengiz 1 , * , Demet Gokalp Yasar 2 , Mehmet Ali Ergun 3 , Gulen Akyol 4 and Seren Ozenirler 5
Authors Information
1 Department of Gastroenterology, Ankara Oncology Training and Research Hospital, Ankara, Turkey
2 Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey
3 Department of Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey
4 Department of Pathology, Faculty of Medicine, Gazi University, Ankara, Turkey
5 Department of Gastroenterology, Faculty of Medicine, Gazi University, Ankara, Turkey
Article information
  • Hepatitis Monthly: December 01, 2014, 14 (12); e24635
  • Published Online: December 24, 2014
  • Article Type: Research Article
  • Received: October 15, 2014
  • Revised: November 25, 2014
  • Accepted: December 7, 2014
  • DOI: 10.5812/hepatmon.24635

To Cite: Cengiz M, Yasar D G, Ergun M A, Akyol G, Ozenirler S. The Role of Interleukin-6 and Interleukin-8 Gene Polymorphisms in Non-Alcoholic Steatohepatitis, Hepat Mon. 2014 ; 14(12):e24635. doi: 10.5812/hepatmon.24635.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34(3): 274-85[DOI][PubMed]
  • 2. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998; 114(4): 842-5[PubMed]
  • 3. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002; 123(5): 1705-25[PubMed]
  • 4. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol. 1994; 56(5): 559-64[PubMed]
  • 5. Bahcecioglu IH, Yalniz M, Ataseven H, Ilhan N, Ozercan IH, Seckin D, et al. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology. 2005; 52(65): 1549-53[PubMed]
  • 6. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology. 2003; 38(2): 413-9[DOI][PubMed]
  • 7. Torer N, Ozenirler S, Yucel A, Bukan N, Erdem O. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. Scand J Gastroenterol. 2007; 42(9): 1095-101[DOI][PubMed]
  • 8. Vairaktaris E, Yapijakis C, Serefoglou Z, Derka S, Vassiliou S, Nkenke E, et al. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol. 2007; 33(4): 504-7[DOI][PubMed]
  • 9. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003; 374: 1-20[DOI][PubMed]
  • 10. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000; 275(24): 18138-44[DOI][PubMed]
  • 11. Franceschi C, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Capri M, et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev. 2005; 126(2): 351-61[DOI][PubMed]
  • 12. Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009; 125(10): 2264-9[DOI][PubMed]
  • 13. Wong VW, Yu J, Cheng AS, Wong GL, Chan HY, Chu ES, et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer. 2009; 124(12): 2766-70[DOI][PubMed]
  • 14. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7): 1369-76[DOI][PubMed]
  • 15. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology. 2003; 37(3): 493-503[DOI][PubMed]
  • 16. Wilfred de Alwis NM, Day CP. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis. 2007; 27(1): 44-54[DOI][PubMed]
  • 17. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, Nemoto Y, Ono M, et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol. 2004; 40(5): 781-6[DOI][PubMed]
  • 18. Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O'Brien PE. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol. 2003; 39(6): 967-71[PubMed]
  • 19. Nozaki Y, Saibara T, Nemoto Y, Ono M, Akisawa N, Iwasaki S, et al. Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis. Alcohol Clin Exp Res. 2004; 28(8 Suppl Proceedings): 106S-10S[PubMed]
  • 20. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94(9): 2467-74[DOI][PubMed]
  • 21. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6): 1313-21[DOI][PubMed]
  • 22. Verma S, Jensen D, Hart J, Mohanty SR. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int. 2013; 33(9): 1398-405[DOI][PubMed]
  • 23. Merriman RB, Aouizerat BE, Bass NM. Genetic influences in nonalcoholic fatty liver disease. J Clin Gastroenterol. 2006; 40 Suppl 1-3[DOI][PubMed]
  • 24. Chu CJ, Lu RH, Wang SS, Chang FY, Lin SY, Yang CY, et al. Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease. Hepatogastroenterology. 2007; 54(79): 2045-8[PubMed]
  • 25. Falleti E, Fabris C, Vandelli C, Colletta C, Cussigh A, Smirne C, et al. Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. Hum Immunol. 2010; 71(10): 999-1004[DOI][PubMed]
  • 26. Matthews VB, Allen TL, Risis S, Chan MH, Henstridge DC, Watson N, et al. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia. 2010; 53(11): 2431-41[DOI][PubMed]
  • 27. Liu S, Qiu XQ, Zeng XY, Bai H, Bei CH, Yang Y. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men]. Zhonghua Gan Zang Bing Za Zhi. 2012; 20(6): 463-7[DOI][PubMed]
  • 28. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut. 2002; 50(5): 585-8[PubMed]
  • 29. Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One. 2012; 7(6)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments